EIKEN CHEMICALConsolidated Financial Resultsfor the Nine Months Ended December 31, 2024 February 7, 2025
EIKEN CHEMICALNotice of Investment in Nanotis, a Startup of Next-gen, Saliva-Based Infectious Disease Digital Testing Technology January 26, 2025
EIKEN CHEMICALConsolidated Financial Results for the Six Months Ended September 30, 2024 January 8, 2025
